Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model-Reference-Cited by-同舟云学术

Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model

Published:2023-11 Issue:11 Volume:5 Page:e821-e830
ISSN:2589-7500
Container-title:The Lancet Digital Health
language:en
Short-container-title:The Lancet Digital Health

Author:

Vartiainen Pekka,Jukarainen Sakari,Rhedin Samuel Arthur,Prinz Alexandra,Hartonen Tuomo,Vabalas Andrius,Viippola Essi,Rodosthenous Rodosthenis S,Koskelainen Sara,Liu Aoxing,Lundholm Cecilia,Smew Awad I,Osvald Emma Caffrey,Helle Emmi,Perola Markus,Almqvist Catarina,Heinonen Santtu,Ganna Andrea

Publisher

Elsevier BV

Subject

Health Information Management,Decision Sciences (miscellaneous),Health Informatics,Medicine (miscellaneous)

Reference30 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022

2. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study;Wildenbeest;Lancet Respir Med,2023

3. A systematic review of European clinical practice guidelines for respiratory syncytial virus prophylaxis;Reeves;J Infect Dis,2022

4. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection;Brady;Pediatrics,2014

5. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for severe disease in pediatric respiratory syncytial virus infections;Public Health;2024-10

2. School holidays and respiratory syncytial virus transmission in Sweden: An interrupted time series analysis;Acta Paediatrica;2024-06-07

3. Monoclonal antibody therapies in respiratory syncytial virus prophylaxis—An umbrella review;Pediatric Pulmonology;2024-05-15

4. Neonatal past catches up when COVID-19 comes to town;Pediatric Research;2024-05-07

5. RSV Severe Infection Risk Stratification in a French 5-Year Birth Cohort Using Machine-learning;Pediatric Infectious Disease Journal;2024-05-07